Alzheimer's disease

Biogen makes another Alzheimer's bet, paying Pfizer $75M for early-phase drug
Fierce Biotech
Mon, 01/13/20 - 10:51 am
Biogen
Alzheimer's disease
Pfizer
PF-05251749
We May Be One Step Closer To A Vaccine Against Alzheimer’s Disease
Forbes
Sun, 01/12/20 - 11:23 pm
vaccines
Alzheimer's disease
3 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2020
Yahoo/Zacks.com
Wed, 01/8/20 - 10:42 am
Alzheimer's disease
Medical Marijuana
Rare Diseases
Biogen and the desperation of a need for Alzheimer's drugs
Fierce Biotech
Fri, 12/20/19 - 08:13 pm
Biogen
FDA
Alzheimer's disease
aducanumab
After Recent Tau Failure, Biogen Licenses Tau Therapeutic from Ionis for Alzheimer's Disease
BioSpace
Thu, 12/19/19 - 01:04 pm
Biogen
Alzheimer's disease
IONIS-MAPTRx
Ionis Pharmaceuticals
Biogen chalks up another failure, but investors' eyes remain firmly on Alzheimer's
Fierce Biotech
Fri, 12/13/19 - 12:26 pm
Biogen
Alzheimer's disease
aducanumab
progressive supranuclear palsy
gosuranemab
clinical trials
Grifols says trial shows positive effects in slowing Alzheimer's
Reuters
Mon, 12/9/19 - 11:35 pm
Grifols
Alzheimer's disease
clinical trials
Biohaven Pharma to continue late-stage study of Alzheimer's treatment
Reuters
Fri, 12/6/19 - 09:34 pm
Biohaven Pharmaceuticals
Alzheimer's disease
troriluzole
Biogen Points to Enrollment and Dosing to Explain Alzheimer’s Results
Xconomy
Thu, 12/5/19 - 11:35 pm
Biogen
Alzheimer's disease
aducanumab
Worldwide Clinical Trials
The clearest picture of Biogen's Alzheimer's drug is still fuzzy
Biopharma Dive
Thu, 12/5/19 - 11:34 pm
Biogen
Alzheimer's disease
clinical trials
aducanumab
New Biogen data showed no major safety issues for its Alzheimer's drug
Reuters
Thu, 12/5/19 - 12:16 pm
Biogen
safety
Alzheimer's disease
aducanumab
clinical trials
6 Experimental Alzheimer’s Disease Diagnostics Projects Get Funding Boost
Xconomy
Wed, 12/4/19 - 11:13 pm
Alzheimer's disease
diagnostics
DiamiR Biosciences
RetiSpec
What to watch as Biogen presents its all-important Alzheimer's data
Biopharma Dive
Wed, 12/4/19 - 11:11 pm
Biogen
clinical trials
Alzheimer's disease
aducanumab
Biogen’s stock could fall 10% on new Alzheimer’s drug data this week, top analyst says
CNBC
Tue, 12/3/19 - 10:18 pm
Biogen
Alzheimer's disease
aducanumab
Analyst: Biogen's aducanumab is not getting approved absent a deus ex machina
Fierce Biotech
Mon, 12/2/19 - 10:44 am
Biogen
aducanumab
FDA
Alzheimer's disease
Why Biogen's Recent Rebound May Not Last -- at Least for Now
Motley Fool
Wed, 11/27/19 - 10:43 am
Biogen
MS
multiple sclerois
Alzheimer's disease
Tecfidera
aducanumab
Biogen’s top scientist nearly dares FDA not to approve Alzheimer’s drug
Stat
Thu, 11/21/19 - 11:20 pm
Biogen
aducanumab
FDA
Alzheimer's disease
Roche tests 'brain shuttle' in humans in Alzheimer's project
Reuters
Mon, 11/11/19 - 08:00 pm
Roche
Alzheimer's disease
monoclonal antibodies
gantenerumab
Here's Why Biogen Stock Shot Up 28% in October
Motley Fool
Sun, 11/10/19 - 07:51 pm
Biogen
Alzheimer's disease
aducanumab
China's Alzheimer’s Drug Approval Raises Hopes and Skepticism
BioSpace
Tue, 11/5/19 - 11:58 pm
Alzheimer's disease
China
Shanghai Green Valley Pharmaceuticals

Pages